Gartner Blog Network

Category: 'pharmaceutical' Blog Posts

from the Gartner Blog Network

2 x Life Science Hype Cycles

by Michael Shanler  |  July 29, 2017

While the spring rains drenched the northeastern U.S. and parts of Europe, Jeff, Steve, and I were hard at work authoring, arranging, writing, reviewing,  re-reviewing, re-re-reviewing our content.  After countless...

Read more »

A CIO’s 24 Hours of Le Mans

by Michael Shanler  |  June 28, 2017

CIOs are competing in an endurance race.  Winning requires carefully orchestrated activities that rely on technology, team work, precision driving, and a bit of luck.   As in racing, the victorious...

Read more »

Hey Ya! Cool Vendors in R&D is out…

by Michael Shanler  |  May 22, 2017

“…Now what's cooler than bein' cool? (Ice cold!)…” - André "André 3000" Benjamin from OutKast André 3000" is the 9th most influential rapper of all time  according to Rateyourmusic.com.  He’s in...

Read more »

Hype Cycle for Life Science R&D

by Michael Shanler  |  July 25, 2016

This year, we unveiled a brand new hype cycle, one that is 100% Life Science R&D-focused. “… the moon does not present the same face every day. It waxes, or grows larger, until...

Read more »

Mutate the DNA of Pharma Externalization

by Michael Shanler  |  May 12, 2016

Here’s a prediction.  Life Science CxOs that continue to oversimplify “externalized innovation” strategies are in for a career-ending surprise in a few years.   For details, check this out:  Industry...

Read more »

Cool Vendors in Life Science

by Michael Shanler  |  April 18, 2016

Allegra, Benadryl, Sudafed, Flonase, Claritin, Zyrtec, Tavist…. Why mention these drugs at this point in time?   Well…Spring is finally here.    Each season many of us spend some quality time with...

Read more »

Dealing with Electronic Trial Masterphobia...

by Michael Shanler  |  April 5, 2016

There's an eTMF monster hiding under the bed… Well, not really...but I did recently have a conversation with a pharma R&D CIO (btw- he pre-approved me to blog about this) who...

Read more »

Hey Pharma, Did you listen to Elon?

by Michael Shanler  |  April 3, 2016

The Tesla Model 3 was unveiled a few days ago.  There are already over 250,000 people plopping down $1,000 deposits to reserve a product they haven’t physically seen or touched...

Read more »

“Accelerating R&D” Key Initiatives for Life Science Manufacturers 2016

by Michael Shanler  |  January 27, 2016

Before each calendar year begins, we put a lot of effort into outlining areas of research and how these areas align with strategic key initiatives (KIs).  The life science-related  KIs...

Read more »

IDMP Compliance Storm is Brewing for Pharma in the EU

by Michael Shanler  |  January 25, 2016

As we dig out in the US from the Winter Storm "Jonas" (aka #Snowmaggedon, #Snowpocalpyse #Blizzgazzhi, #Blizzard2016) and deal with snarled traffic, delayed flights and rescheduled meetings...it reminds me that...

Read more »